| (EUR) | Dec 2024 | Y/Y change |
|---|---|---|
| Revenue | 891.04M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, C1S.F returned +98.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +73.7% |
| 1 year | +98.8% |
| 5 years | +4652.5% |
| 10 years | +60446.8% |
| All-time high | €1.87 (May 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in C1S.F would be worth today ›Yes. China Shineway Pharmaceutical Group Limited paid 2 dividends over the past 12 months. The most recent was €0.05 per share on May 4, 2026. The dividend yield is 7.83%.
China Shineway Pharmaceutical Group Limited is part of the Healthcare sector.
China Shineway Pharmaceutical Group Limited has a market cap of 638.31M EUR, based on the latest quote.
